Talk:Peripheral defocus

AI prompt

The text of this article was created with an assistance of Google Gemini Pro 3.0 and Claude Opus 4.6. Extensive manual editing was applied. The main prompt (Gemini) was:

• Using the attached source, create wikitext code for he article "Peripheral defocus"

--Викидим (talk) 20:24, 14 March 2026 (UTC)

Verification

Generated by Google Gemini Pro 3.0. The main prompts were:

• check the claims in the manually updated wikitext, detect close paraphrasing: [text]
• create wikitext code for claim verification section

Intro and theories of eye growth

• Claim: Peripheral blur is a major factor in myopia progression, and animal studies (like the rhesus monkey foveal ablation study) show peripheral regions guide emmetropization independently.
• Status: Confirmed. The source explicitly notes that peripheral hyperopic blur is a risk factor and that rhesus monkeys still experienced refractive changes after their foveae were ablated, proving the peripheral retina's role (page 71).
• Claim: Blur triggers chemical mediators (dopamine, retinoic acid, nitric oxide) that alter the scleral extracellular matrix and cause the eye to elongate.
• Status: Confirmed. The source identifies these exact biochemical compounds and their role in modulating the choroid and scleral extracellular matrix to cause ocular growth (page 72).

Optical devices and management

• Claim: Single-vision lenses shift the peripheral focal point further behind the retina, worsening with higher prescriptions.
• Status: Confirmed. The text states that single vision lenses increase hyperopic defocus at the periphery, and the magnitude increases alongside the amount of myopia correction (page 73).
• Claim: Progressive lenses showed only about a 0.20 diopter difference over three years, which is statistically significant but clinically modest.
• Status: Confirmed. The source notes a change of 0.20 diopters over a 3-year period that is statistically significant but clinically insignificant (page 73).
• Claim: DIMS (Hoya) and HALT (Essilor) designs use lenslets around a central clear zone and demonstrate roughly 60% efficacy.
• Status: Confirmed. The source describes the DIMS central optical zone surrounded by multiple segments and the Stellest central vision area with radiating aspheric lenslets, confirming both have an effectivity of about 60% (pages 73-74).
• Claim: Orthokeratology flattens the center and steepens the mid-periphery, reducing progression by about 50%.
• Status: Confirmed. The text verifies the lenses flatten the central cornea, steepen the mid-peripheral cornea, and result in an overall myopia progression decrease of around 50% (page 75).
• Claim: Soft lenses range from about 25% to over 70% efficacy.
• Status: Confirmed. The source explicitly states the reduction in myopia progression varies from 25% to over 70% (pages 75-76).

Викидим (talk) 20:14, 14 March 2026 (UTC)